|
MCFD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.37519995391244E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.94577687295805E-12 |
| Normal-vs-Stage2 |
8.520800E-03 |
| Normal-vs-Stage3 |
8.335200E-03 |
| Normal-vs-Stage4 |
1.493990E-01 |
| Stage1-vs-Stage2 |
4.696000E-01 |
| Stage1-vs-Stage3 |
1.407840E-02 |
| Stage1-vs-Stage4 |
1.243770E-03 |
| Stage2-vs-Stage3 |
4.116800E-01 |
| Stage2-vs-Stage4 |
1.422200E-01 |
| Stage3-vs-Stage4 |
4.151800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.49400491977758E-11 |
| Normal-vs-AfricanAmerican |
9.376000E-01 |
| Normal-vs-Asian |
8.680200E-02 |
| Caucasian-vs-AfricanAmerican |
1.417820E-04 |
| Caucasian-vs-Asian |
9.948800E-01 |
| AfricanAmerican-vs-Asian |
1.196600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70950000050385E-07 |
| Normal-vs-Female |
6.07969996568869E-09 |
| Male-vs-Female |
3.842100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.407200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.4108000009131E-08 |
| Normal-vs-Age(61-80Yrs) |
4.3440000041528E-08 |
| Normal-vs-Age(81-100Yrs) |
7.518000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.870230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.799250E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.329400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.339400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.526800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.228400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.904020E-03 |
| Normal-vs-Grade 2 |
3.9199754553465E-12 |
| Normal-vs-Grade 3 |
5.69149999999352E-05 |
| Normal-vs-Grade 4 |
6.066800E-01 |
| Grade 1-vs-Grade 2 |
4.740400E-01 |
| Grade 1-vs-Grade 3 |
1.124600E-01 |
| Grade 1-vs-Grade 4 |
8.176200E-03 |
| Grade 2-vs-Grade 3 |
1.347940E-02 |
| Grade 2-vs-Grade 4 |
8.37460000000512E-05 |
| Grade 3-vs-Grade 4 |
3.422200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
2.515700E-02 |
| ccA subtype-vs-ccB subtype |
9.33849997331038E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.4700999851367E-09 |
| Normal-vs-N1 |
2.871400E-01 |
| N0-vs-N1 |
6.665400E-01 |
|
|
